Since two reports have demonstrated that PTEN mutations or deletions are not present in pancreatic cancers (Sakurada et al, 1997; Okami et al, 1998), other molecular mechanisms must contribute to its altered expression in pancreatic cancer. This evidence concerns the gene PTEN and pancreatic neoplasm.